+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Toxoplasmosis Test"

2022-2026 Global Toxoplasmosis Diagnostic Testing Market: US, Europe, Japan - Product Thumbnail Image

2022-2026 Global Toxoplasmosis Diagnostic Testing Market: US, Europe, Japan

  • Report
  • April 2022
  • Japan, United States, ... Japan, United States, Europe, Global
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

The Toxoplasmosis Test is a type of Infectious Disease Testing used to detect the presence of the parasite Toxoplasma gondii in a patient's blood. It is used to diagnose toxoplasmosis, an infection caused by the parasite, which can cause serious health problems in pregnant women and those with weakened immune systems. The test is typically performed using a blood sample, which is then tested for the presence of antibodies to the parasite. If antibodies are present, it indicates that the patient has been infected with the parasite. The Toxoplasmosis Test market is a subset of the larger Infectious Disease Testing market, which is estimated to be worth billions of dollars. The market is expected to grow in the coming years due to the increasing prevalence of infectious diseases, as well as the development of new technologies and tests. Some companies in the Toxoplasmosis Test market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and DiaSorin. Show Less Read more